Zhang Shuai-Tong, Wang Si-Yun, Zhang Jie, Dong Di, Mu Wei, Xia Xue-Er, Fu Fang-Fang, Lu Ya-Nan, Wang Shuo, Tang Zhen-Chao, Li Peng, Qu Jin-Rong, Wang Mei-Yun, Tian Jie, Liu Jian-Hua
School of Medical Technology, Beijing Institute of Technology, Beijing, China.
Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, School of Engineering Medicine, Beihang University, Beijing, China.
Heliyon. 2023 Feb 25;9(3):e14030. doi: 10.1016/j.heliyon.2023.e14030. eCollection 2023 Mar.
This study aimed to develop an artificial intelligence-based computer-aided diagnosis system (AI-CAD) emulating the diagnostic logic of radiologists for lymph node metastasis (LNM) in esophageal squamous cell carcinoma (ESCC) patients, which contributed to clinical treatment decision-making.
A total of 689 ESCC patients with PET/CT images were enrolled from three hospitals and divided into a training cohort and two external validation cohorts. 452 CT images from three publicly available datasets were also included for pretraining the model. Anatomic information from CT images was first obtained automatically using a U-Net-based multi-organ segmentation model, and metabolic information from PET images was subsequently extracted using a gradient-based approach. AI-CAD was developed in the training cohort and externally validated in two validation cohorts.
The AI-CAD achieved an accuracy of 0.744 for predicting pathological LNM in the external cohort and a good agreement with a human expert in two external validation cohorts (kappa = 0.674 and 0.587, < 0.001). With the aid of AI-CAD, the human expert's diagnostic performance for LNM was significantly improved (accuracy [95% confidence interval]: 0.712 [0.669-0.758] vs. 0.833 [0.797-0.865], specificity [95% confidence interval]: 0.697 [0.636-0.753] vs. 0.891 [0.851-0.928]; < 0.001) among patients underwent lymphadenectomy in the external validation cohorts.
The AI-CAD could aid in preoperative diagnosis of LNM in ESCC patients and thereby support clinical treatment decision-making.
本研究旨在开发一种基于人工智能的计算机辅助诊断系统(AI-CAD),该系统可模拟放射科医生对食管鳞状细胞癌(ESCC)患者淋巴结转移(LNM)的诊断逻辑,有助于临床治疗决策。
从三家医院招募了689例有PET/CT图像的ESCC患者,并将其分为一个训练队列和两个外部验证队列。还纳入了来自三个公开可用数据集的452张CT图像用于模型预训练。首先使用基于U-Net的多器官分割模型自动获取CT图像的解剖信息,随后使用基于梯度的方法提取PET图像的代谢信息。在训练队列中开发AI-CAD,并在两个验证队列中进行外部验证。
AI-CAD在外部队列中预测病理性LNM的准确率为0.744,并且在两个外部验证队列中与人类专家的诊断结果具有良好的一致性(kappa = 0.674和0.587,<0.001)。在AI-CAD的辅助下,人类专家对LNM的诊断性能显著提高(准确率[95%置信区间]:0.712[0.669 - 0.758]对0.833[0.797 - 0.865],特异性[95%置信区间]:0.697[0.636 - 0.753]对0.891[0.851 - 0.928];<0.001),这些患者来自外部验证队列中接受了淋巴结切除术的患者。
AI-CAD有助于ESCC患者LNM的术前诊断,从而支持临床治疗决策。